10.27.2022
SAB Biotherapeutics Announces Exclusive Manufacturing Partnership with Emergent BioSolutions
SIOUX FALLS, S.D. and GAITHERSBURG, Md., Oct. 27, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), ("SAB”), a...
10.27.2022
SIOUX FALLS, S.D. and GAITHERSBURG, Md., Oct. 27, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), ("SAB”), a...
09.01.2022
For nearly 25 years, Emergent has developed, manufactured, and delivered their own innovative vaccines and biotherapeutic...
03.21.2022
As a CDMO, Emergent has been working for more than two decades to develop, manufacture, and deliver protections against public...
03.14.2022
Emergent is pleased to announce the addition of two senior leaders to its CDMO and Quality & Compliance organizations.
03.11.2022
Dino Muzzin, senior vice president of manufacturing operations at Emergent BioSolutions recently shared his insights with Pharma...
07.23.2021
With the expansion of our viral drug product manufacturing facility in Rockville, Maryland well underway, we have begun...